Cambium Bio Ltd (ASX: CMB) — Healthcare · Share Price, Chart & Market Data
About: Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.45 (+5.88%)
CMBCambium Bio Ltd
Loading watchlist status…
Trade CMB now
Cambium Bio Ltd share price
CMB price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:59 am GMT+0
CMB price performance
2.273%
5D
-6.25%
1M
-3.226%
YTD
55.172%
1Y
CMB price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:59 am GMT+0
CMB details
CMB Market Signals